25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
Buy, Hold or Sell?

Let's analyze Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. together

I guess you are interested in Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.

I send you an email if I find something interesting about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

1. Quick Overview

1.1. Quick analysis of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (30 sec.)










1.2. What can you expect buying and holding a share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥25.64
Expected worth in 1 year
¥27.98
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.75
Return On Investment
6.6%

For what price can you sell your share?

Current Price per Share
¥41.50
Expected price per share
¥33.57 - ¥56.98
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (5 min.)




Live pricePrice per Share (EOD)
¥41.50

2.2. Growth of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (5 min.)




Is Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. growing?

Current yearPrevious yearGrowGrow %
How rich?$387m$344.7m$29.3m7.8%

How much money is Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. making?

Current yearPrevious yearGrowGrow %
Making money$9.9m$7.8m$2m20.3%
Net Profit Margin25.5%28.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.?

Welcome investor! Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s management wants to use your money to grow the business. In return you get a share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

First you should know what it really means to hold a share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. And how you can make/lose money.

Speculation

The Price per Share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is ¥41.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥25.64. Based on the TTM, the Book Value Change Per Share is ¥0.59 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.110.3%0.090.2%0.070.2%0.080.2%0.080.2%
Usd Book Value Change Per Share0.080.2%0.080.2%0.060.2%0.350.9%0.350.9%
Usd Dividend Per Share0.050.1%0.010.0%0.030.1%0.030.1%0.030.1%
Usd Total Gains Per Share0.120.3%0.090.2%0.090.2%0.380.9%0.380.9%
Usd Price Per Share8.03-9.21-8.86-9.47-9.47-
Price to Earnings Ratio18.79-26.96-34.14-39.37-39.37-
Price-to-Total Gains Ratio66.01-103.58-102.21-95.40-95.40-
Price to Book Ratio2.27-2.70-2.81-2.96-2.96-
Price-to-Total Gains Ratio66.01-103.58-102.21-95.40-95.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.7353
Number of shares174
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.03
Usd Book Value Change Per Share0.080.35
Usd Total Gains Per Share0.090.38
Gains per Quarter (174 shares)16.5166.05
Gains per Year (174 shares)66.05264.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110565618247254
21911312235493518
32916918853740782
439225254709871046
5482823208812331310
65833838610514801574
76839545212317261838
87845151814019732102
98750758415822202366
109756465017624662630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Dividend per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5430.586-7%0.466+17%2.564-79%2.564-79%
Book Value Per Share--25.64124.780+3%22.836+12%23.330+10%23.330+10%
Current Ratio--1.8421.940-5%5.216-65%5.326-65%5.326-65%
Debt To Asset Ratio--0.2840.269+6%0.183+55%0.203+40%0.203+40%
Debt To Equity Ratio--0.3970.368+8%0.229+73%0.264+51%0.264+51%
Dividend Per Share--0.3370.101+234%0.204+65%0.183+85%0.183+85%
Eps--0.7730.656+18%0.523+48%0.550+41%0.550+41%
Free Cash Flow Per Share---0.611-1.482+143%-1.216+99%-1.231+101%-1.231+101%
Free Cash Flow To Equity Per Share---0.611-1.482+143%-1.216+99%-1.231+101%-1.231+101%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap4532962000.000-40%6343962240.0007282230760.000-13%7001241730.000-9%7485176384.000-15%7485176384.000-15%
Net Profit Margin--0.2730.255+7%0.286-5%0.280-3%0.280-3%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.9841.045-6%1.052-6%1.061-7%1.061-7%
Pb Ratio1.619-40%2.2652.695-16%2.808-19%2.959-23%2.959-23%
Pe Ratio13.428-40%18.79326.956-30%34.142-45%39.368-52%39.368-52%
Price Per Share41.500-40%58.08066.670-13%64.098-9%68.528-15%68.528-15%
Price To Free Cash Flow Ratio-16.981+29%-23.765-15.259-36%-19.916-16%-23.951+1%-23.951+1%
Price To Total Gains Ratio47.165-40%66.008103.583-36%102.209-35%95.404-31%95.404-31%
Quick Ratio--0.4650.311+49%0.452+3%0.428+9%0.428+9%
Return On Assets--0.0220.019+11%0.019+16%0.018+17%0.018+17%
Return On Equity--0.0300.027+14%0.023+32%0.023+29%0.023+29%
Total Gains Per Share--0.8800.687+28%0.670+31%2.747-68%2.747-68%
Usd Book Value--387055849.349374055467.056+3%344714150.506+12%352175134.045+10%352175134.045+10%
Usd Book Value Change Per Share--0.0750.081-7%0.064+17%0.354-79%0.354-79%
Usd Book Value Per Share--3.5443.425+3%3.156+12%3.224+10%3.224+10%
Usd Dividend Per Share--0.0470.014+234%0.028+65%0.025+85%0.025+85%
Usd Eps--0.1070.091+18%0.072+48%0.076+41%0.076+41%
Usd Free Cash Flow---9222881.794-22370198.827+143%-18361884.305+99%-18582781.810+101%-18582781.810+101%
Usd Free Cash Flow Per Share---0.084-0.205+143%-0.168+99%-0.170+101%-0.170+101%
Usd Free Cash Flow To Equity Per Share---0.084-0.205+143%-0.168+99%-0.170+101%-0.170+101%
Usd Market Cap626455348.400-40%876735581.5681006404291.032-13%967571607.086-9%1034451376.269-15%1034451376.269-15%
Usd Price Per Share5.735-40%8.0279.214-13%8.858-9%9.471-15%9.471-15%
Usd Profit--11663016.5579906034.185+18%7898250.224+48%8296707.560+41%8296707.560+41%
Usd Revenue--42753371.45338649273.695+11%27142634.558+58%29711897.133+44%29711897.133+44%
Usd Total Gains Per Share--0.1220.095+28%0.093+31%0.380-68%0.380-68%
 EOD+3 -5MRQTTM+25 -9YOY+26 -85Y+21 -1310Y+21 -13

3.3 Fundamental Score

Let's check the fundamental score of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.428
Price to Book Ratio (EOD)Between0-11.619
Net Profit Margin (MRQ)Greater than00.273
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.465
Current Ratio (MRQ)Greater than11.842
Debt to Asset Ratio (MRQ)Less than10.284
Debt to Equity Ratio (MRQ)Less than10.397
Return on Equity (MRQ)Greater than0.150.030
Return on Assets (MRQ)Greater than0.050.022
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.163
Ma 20Greater thanMa 5041.441
Ma 50Greater thanMa 10040.333
Ma 100Greater thanMa 20042.756
OpenGreater thanClose41.850
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registration applications. The company was founded in 2011 and is headquartered in Hangzhou, China.

Fundamental data was last updated by Penke on 2024-11-12 08:51:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 27.3% means that ¥0.27 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 27.3%. The company is making a huge profit. +2
  • The TTM is 25.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.3%TTM25.5%+1.8%
TTM25.5%YOY28.6%-3.2%
TTM25.5%5Y28.0%-2.6%
5Y28.0%10Y28.0%0.0%
4.3.1.2. Return on Assets

Shows how efficient Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • 2.2% Return on Assets means that Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 2.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.2%TTM1.9%+0.2%
TTM1.9%YOY1.9%+0.1%
TTM1.9%5Y1.8%+0.1%
5Y1.8%10Y1.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • 3.0% Return on Equity means Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 3.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM2.7%+0.4%
TTM2.7%YOY2.3%+0.4%
TTM2.7%5Y2.3%+0.3%
5Y2.3%10Y2.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is operating .

  • Measures how much profit Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are ¥0.98 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 0.984. The company is less efficient in keeping operating costs low.
  • The TTM is 1.045. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.984TTM1.045-0.061
TTM1.045YOY1.052-0.007
TTM1.0455Y1.061-0.016
5Y1.06110Y1.0610.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.84 means the company has ¥1.84 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 1.842. The company is able to pay all its short-term debts. +1
  • The TTM is 1.940. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.842TTM1.940-0.098
TTM1.940YOY5.216-3.277
TTM1.9405Y5.326-3.386
5Y5.32610Y5.3260.000
4.4.3.2. Quick Ratio

Measures if Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.46 means the company can pay off ¥0.46 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 0.465. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.311. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.311+0.154
TTM0.311YOY0.452-0.141
TTM0.3115Y0.428-0.117
5Y0.42810Y0.4280.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.28 means that Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. assets are financed with 28.4% credit (debt) and the remaining percentage (100% - 28.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 0.284. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.269. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.284TTM0.269+0.016
TTM0.269YOY0.183+0.086
TTM0.2695Y0.203+0.066
5Y0.20310Y0.2030.000
4.5.4.2. Debt to Equity Ratio

Measures if Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 39.7% means that company has ¥0.40 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The MRQ is 0.397. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.368. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.397TTM0.368+0.029
TTM0.368YOY0.229+0.139
TTM0.3685Y0.264+0.104
5Y0.26410Y0.2640.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. generates.

  • Above 15 is considered overpriced but always compare Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. to the Drug Manufacturers - General industry mean.
  • A PE ratio of 18.79 means the investor is paying ¥18.79 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The EOD is 13.428. Based on the earnings, the company is underpriced. +1
  • The MRQ is 18.793. Based on the earnings, the company is fair priced.
  • The TTM is 26.956. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.428MRQ18.793-5.365
MRQ18.793TTM26.956-8.163
TTM26.956YOY34.142-7.186
TTM26.9565Y39.368-12.412
5Y39.36810Y39.3680.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The EOD is -16.981. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.765. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.259. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.981MRQ-23.765+6.784
MRQ-23.765TTM-15.259-8.506
TTM-15.259YOY-19.916+4.656
TTM-15.2595Y-23.951+8.692
5Y-23.95110Y-23.9510.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 2.27 means the investor is paying ¥2.27 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.:

  • The EOD is 1.619. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.265. Based on the equity, the company is underpriced. +1
  • The TTM is 2.695. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.619MRQ2.265-0.647
MRQ2.265TTM2.695-0.430
TTM2.695YOY2.808-0.113
TTM2.6955Y2.959-0.264
5Y2.95910Y2.9590.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,912,627
Total Liabilities1,111,933
Total Stockholder Equity2,800,243
 As reported
Total Liabilities 1,111,933
Total Stockholder Equity+ 2,800,243
Total Assets = 3,912,627

Assets

Total Assets3,912,627
Total Current Assets1,734,845
Long-term Assets2,177,781
Total Current Assets
Cash And Cash Equivalents 615,454
Short-term Investments 83,660
Net Receivables 353,977
Inventory 152,317
Other Current Assets 62,788
Total Current Assets  (as reported)1,734,845
Total Current Assets  (calculated)1,268,195
+/- 466,650
Long-term Assets
Property Plant Equipment 1,805,032
Intangible Assets 104,831
Long-term Assets Other 57,133
Long-term Assets  (as reported)2,177,781
Long-term Assets  (calculated)1,966,995
+/- 210,786

Liabilities & Shareholders' Equity

Total Current Liabilities941,860
Long-term Liabilities170,073
Total Stockholder Equity2,800,243
Total Current Liabilities
Short Long Term Debt 633,876
Accounts payable 173,379
Total Current Liabilities  (as reported)941,860
Total Current Liabilities  (calculated)807,256
+/- 134,605
Long-term Liabilities
Long term Debt 40,023
Capital Lease Obligations Min Short Term Debt849
Long-term Liabilities Other 92,187
Long-term Liabilities  (as reported)170,073
Long-term Liabilities  (calculated)133,059
+/- 37,014
Total Stockholder Equity
Retained Earnings 545,983
Total Stockholder Equity (as reported)2,800,243
Total Stockholder Equity (calculated)545,983
+/- 2,254,260
Other
Capital Stock108,920
Common Stock Shares Outstanding 108,920
Net Debt 58,445
Net Invested Capital 3,474,141
Net Working Capital 792,985
Property Plant and Equipment Gross 1,805,032



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
2,616,781
2,641,626
2,722,803
2,929,705
3,246,045
3,381,523
3,406,099
3,669,106
3,834,691
3,912,627
3,912,6273,834,6913,669,1063,406,0993,381,5233,246,0452,929,7052,722,8032,641,6262,616,781
   > Total Current Assets 
1,888,799
1,747,059
1,660,471
1,609,891
1,755,102
1,670,696
1,558,715
1,607,784
1,669,572
1,734,845
1,734,8451,669,5721,607,7841,558,7151,670,6961,755,1021,609,8911,660,4711,747,0591,888,799
       Cash And Cash Equivalents 
1,634,060
1,517,930
1,341,573
1,238,789
1,281,826
1,079,047
921,139
881,929
790,555
615,454
615,454790,555881,929921,1391,079,0471,281,8261,238,7891,341,5731,517,9301,634,060
       Short-term Investments 
0
0
0
0
0
0
0
0
0
83,660
83,660000000000
       Net Receivables 
99,708
80,628
111,115
149,516
188,549
196,763
194,253
199,920
248,417
353,977
353,977248,417199,920194,253196,763188,549149,516111,11580,62899,708
       Inventory 
31,019
41,382
55,354
66,051
75,850
90,854
87,658
93,174
123,746
152,317
152,317123,74693,17487,65890,85475,85066,05155,35441,38231,019
       Other Current Assets 
44,727
12,319
18,970
21,806
29,993
37,658
43,495
54,119
75,981
62,788
62,78875,98154,11943,49537,65829,99321,80618,97012,31944,727
   > Long-term Assets 
727,982
894,567
1,062,331
1,319,813
1,490,943
1,710,827
1,847,385
2,061,322
2,165,119
2,177,781
2,177,7812,165,1192,061,3221,847,3851,710,8271,490,9431,319,8131,062,331894,567727,982
       Property Plant Equipment 
0
0
0
0
1,199,840
1,356,778
1,490,146
1,740,571
1,821,919
1,805,032
1,805,0321,821,9191,740,5711,490,1461,356,7781,199,8400000
       Intangible Assets 
67,687
66,944
66,341
82,369
81,689
81,019
80,386
92,070
92,784
104,831
104,83192,78492,07080,38681,01981,68982,36966,34166,94467,687
       Long-term Assets Other 
26,245
21,488
46,678
21,597
51,382
83,704
79,334
43,140
55,780
57,133
57,13355,78043,14079,33483,70451,38221,59746,67821,48826,245
> Total Liabilities 
278,625
300,528
305,608
447,445
712,937
836,831
805,822
984,969
1,093,302
1,111,933
1,111,9331,093,302984,969805,822836,831712,937447,445305,608300,528278,625
   > Total Current Liabilities 
139,489
157,515
177,076
290,700
532,360
629,827
682,557
846,191
963,418
941,860
941,860963,418846,191682,557629,827532,360290,700177,076157,515139,489
       Short Long Term Debt 
0
0
0
0
250,078
280,210
290,218
369,320
634,024
633,876
633,876634,024369,320290,218280,210250,0780000
       Accounts payable 
51,853
58,983
68,057
167,025
161,423
221,003
239,702
323,381
233,871
173,379
173,379233,871323,381239,702221,003161,423167,02568,05758,98351,853
   > Long-term Liabilities 
139,136
143,013
128,533
156,745
180,576
207,004
123,265
138,778
129,884
170,073
170,073129,884138,778123,265207,004180,576156,745128,533143,013139,136
       Long term Debt 
39,679
39,251
0
0
0
0
0
0
0
40,023
40,023000000039,25139,679
       Capital Lease Obligations Min Short Term Debt
5,133
3,600
2,891
0
189
0
0
933
913
849
8499139330018902,8913,6005,133
       Long-term Liabilities Other 
94,318
100,157
125,636
150,970
174,658
201,531
78,332
97,170
89,466
92,187
92,18789,46697,17078,332201,531174,658150,970125,636100,15794,318
> Total Stockholder Equity
2,338,325
2,341,299
2,417,361
2,482,518
2,533,108
2,544,693
2,600,278
2,684,137
2,741,389
2,800,243
2,800,2432,741,3892,684,1372,600,2782,544,6932,533,1082,482,5182,417,3612,341,2992,338,325
   Common Stock0000000000
   Retained Earnings 
182,824
183,416
243,616
270,465
305,534
303,393
385,419
444,215
494,033
545,983
545,983494,033444,215385,419303,393305,534270,465243,616183,416182,824
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,017,448
Cost of Revenue-350,737
Gross Profit666,711666,711
 
Operating Income (+$)
Gross Profit666,711
Operating Expense-719,540
Operating Income297,908-52,829
 
Operating Expense (+$)
Research Development241,017
Selling General Administrative86,337
Selling And Marketing Expenses0
Operating Expense719,540327,354
 
Net Interest Income (+$)
Interest Income28,240
Interest Expense-412
Other Finance Cost-273
Net Interest Income27,554
 
Pretax Income (+$)
Operating Income297,908
Net Interest Income27,554
Other Non-Operating Income Expenses0
Income Before Tax (EBT)295,679297,908
EBIT - interestExpense = -412
271,966
272,378
Interest Expense412
Earnings Before Interest and Taxes (EBIT)0296,091
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax295,679
Tax Provision-23,665
Net Income From Continuing Ops272,015272,015
Net Income271,966
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-27,554
 

Technical Analysis of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The general trend of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 45.24 < 45.52 < 56.98.

The bearish price targets are: 38.13 > 37.44 > 33.57.

Tweet this
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current macd is 0.11703394.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current adx is 17.39.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current sar is 39.56.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current rsi is 50.16. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Relative Strength Index (RSI) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Stochastic Oscillator ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current cci is 5.19240801.

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Commodity Channel Index (CCI) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current cmo is -0.85367182.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Chande Momentum Oscillator (CMO) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current willr is -58.51528384.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Williams %R ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current atr is 1.88068513.

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Average True Range (ATR) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current obv is 22,759,953.

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily On-Balance Volume (OBV) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. The current mfi is 70.09.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Money Flow Index (MFI) ChartHangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.163
Ma 20Greater thanMa 5041.441
Ma 50Greater thanMa 10040.333
Ma 100Greater thanMa 20042.756
OpenGreater thanClose41.850
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. with someone you think should read this too:
  • Are you bullish or bearish on Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.

I send you an email if I find something interesting about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..

Receive notifications about Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.